Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant part » significant gap (Expand Search), significant portion (Expand Search), significant factor (Expand Search)
part decrease » point decrease (Expand Search), bfrt decreased (Expand Search), a decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant part » significant gap (Expand Search), significant portion (Expand Search), significant factor (Expand Search)
part decrease » point decrease (Expand Search), bfrt decreased (Expand Search), a decrease (Expand Search)
-
281
Chemical compositions of <i>U.simensis</i> essential oil identified through GC-MS analysis.
Published 2025Subjects: -
282
-
283
Fetal outcomes of gravid rats treated with <i>U.simensis</i> essential oil.
Published 2025Subjects: -
284
-
285
-
286
Dietary intake and weight gain of pregnant dams treated with <i>U. simensis</i> essential oil.
Published 2025Subjects: -
287
-
288
-
289
-
290
-
291
-
292
-
293
UPLC-ESI/MS-MS based characterization of phytoconstituents of the ethanol (EtOH) and ethyl acetate (EtOAc) extracts of <i><i>T. oliverianum</i></i> above-ground parts in negative i...
Published 2025Subjects: “…extracts considerably decreased…”
-
294
Expression pattern of statistically significantly differentially expressed immune-related genes in CL patients compared to healthy volunteers.
Published 2025“…The red and blue colors of the bar plot represent relative significant increased or decreased expression of the genes in patients compared to healthy samples. …”
-
295
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
296
-
297
-
298
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
299
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
300